Malaysia Apigenin Market Outlook

as the world economy continues developing, herbal medicines are becoming increasingly popular and sought after in many parts of the world. one of these potential beneficiaries is malaysia’s apigenin market, the use of which has been growing steadily over the past few years. the malaysian government has taken strong steps to promote the use of herbal and traditional medicines, of which apigenin from the chamomile plant is a prime example. with economic growth continuing to occur, and with an increasing number of people wanting to reduce their dependence on synthetic drugs, the demand for apigenin is expected to remain strong over the coming years. in addition, the country’s culture, being primarily malay, has a strong tradition of using traditional and natural remedy for many of its ailments. this cultural environment has certainly helped to foster the growing demand for apigenin within the country. this is expected to remain the same well into the next decade. the current availability of apigenin in the country cannot meet the rising demand. to address this, efforts are being made to enhance production in the local market, as well as encouraging foreign investment in field of pharmaceuticals. this will surely contribute to a more healthy and sustainable production as well as a better overall market outlook in the future. furthermore, over the coming years, the malaysian government is expected to continue relaxing regulations on the import and export of medicinal plants containing apigenin. this is expected to open up new opportunities for local distributors and importers, while also providing easier access to the product for consumers. all things considered, the outlook for the malaysian apigenin market appears positive for the period between 2018 and 2032. growing demand, coupled with improved production, availability and better access, suggests that the market will remain strong and viable over the coming years.